Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation-Reference-Cited by-同舟云学术

Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation

Published:2018-10 Issue:10 Volume:11 Page:
ISSN:1941-3289
Container-title:Circulation: Heart Failure
language:en
Short-container-title:Circ Heart Fail

Author:

Luo Nancy¹,Xu Haolin¹,Jneid Hani²,Fonarow Gregg C.,Lopes Renato D.¹³⁴,Piccini Jonathan P.¹³⁴,Curtis Anne B.⁵,Russo Andrea M.⁶,Lewis William R.⁷,Matsouaka Roland A.¹,Granger Christopher B.¹³⁴,Mentz Robert J.¹³⁴,Al-Khatib Sana M.¹³⁴

Affiliation:

1. Division of Cardiovascular Medicine, University of California (Davis) Medical Center, Sacramento (N.L.).

2. Department of Medicine, Baylor College of Medicine, Houston, TX (H.J.).

3. Duke Clinical Research Institute, Durham, NC (H.X., R.D.L., J.P.P., R.A.M., C.B.G., R.J.M., S.M.A.-K.).

4. Department of Medicine, Duke University School of Medicine, Durham, NC (R.D.L., J.P.P., C.B.G., R.J.M., S.M.A.-K.).

5. Department of Medicine, University at Buffalo, NY (A.B.C.).

6. Department of Medicine, Cooper Medical School of Rowan University, Camden, NJ (A.M.R.).

7. MetroHealth System Campus, Case Western Reserve University, Cleveland, OH (W.R.L.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference41 articles.

1. Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association

2. Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population

3. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials

4. Atrial Fibrillation and Outcomes in Heart Failure With Preserved Versus Reduced Left Ventricular Ejection Fraction

5. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart failure with mildly reduced and preserved ejection fraction: A review of disease burden and remaining unmet medical needs within a new treatment landscape;Heart Failure Reviews;2024-02-27

2. Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients With Atrial Fibrillation in the United States;Circulation: Cardiovascular Quality and Outcomes;2023-12

3. Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients with Atrial Fibrillation;2023-03-18

4. From background to solutions: Eliminating sex gaps in clinical electrophysiology practice;Heart Rhythm O2;2022-12

5. Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial;Circulation;2022-09-20